BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30775879)

  • 1. PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics.
    Wang B; Xu L; Ge Y; Cai X; Li Q; Yu Z; Wang J; Wang Y; Lu C; Wang D; Wang Y; Chen X; Gu Y
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.
    Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X
    Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
    Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLOD3 promotes lung metastasis via regulation of STAT3.
    Baek JH; Yun HS; Kwon GT; Kim JY; Lee CW; Song JY; Um HD; Kang CM; Park JK; Kim JS; Kim EH; Hwang SG
    Cell Death Dis; 2018 Nov; 9(12):1138. PubMed ID: 30442941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Profiling Identifies
    Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
    Front Immunol; 2021; 12():722807. PubMed ID: 34646265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.
    Wang D; Zhang S; Chen F
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):366-373. PubMed ID: 29723071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway.
    Baek JH; Yun HS; Kwon GT; Lee J; Kim JY; Jo Y; Cho JM; Lee CW; Song JY; Ahn J; Kim JS; Kim EH; Hwang SG
    Cell Death Dis; 2019 Feb; 10(3):156. PubMed ID: 30770789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma.
    Deng X; Pan Y; Yang M; Liu Y; Li J
    Biomed Res Int; 2021; 2021():4714526. PubMed ID: 34239923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.
    Tsai CK; Huang LC; Tsai WC; Huang SM; Lee JT; Hueng DY
    Oncotarget; 2018 Mar; 9(21):15705-15720. PubMed ID: 29644003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
    Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
    Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
    Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
    Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival.
    Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L
    Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
    Zhang S; Xu J; Wang H; Guo H
    Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.
    Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D
    Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.